Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left‐sided heart diseases

Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left‐sided heart diseases

Abstract Aims The pathophysiology of pulmonary hypertension (PH) due to left‐sided heart disease (Group 2 PH) is distinct from that of other groups of PH, yet there are still no approved therapies that selectively target pulmonary circulation. The increase in pulmonary capillary pressure due to left...

Full description

Bibliographic Details
Main Authors: Taijyu Satoh, Nobuhiro Yaoita, Kotaro Nochioka, Shunsuke Tatebe, Hideka Hayashi, Saori Yamamoto, Haruka Sato, Hiroyuki Takahama, Hideaki Suzuki, Yosuke Terui, Kaito Yamada, Yusuke Yamada, Takumi Inoue, Tatsuo Aoki, Kimio Satoh, Koichiro Sugimura, Satoshi Miyata, Satoshi Yasuda
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:ESC Heart Failure
Subjects:
Inhaled nitric oxide vasoreactivity tests
Pulmonary hypertension
Heart failure with preserved ejection fraction
Heart failure with reduced ejection fraction
Online Access:https://doi.org/10.1002/ehf2.14515

Internet

https://doi.org/10.1002/ehf2.14515

Similar Items